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Background: Spirogyra neglecta (SN) has many nutritional beneﬁts and it is commonly used
to  ameliorate different human conditions including inﬂammation, gastric ulcer, hyper-
glycemia, and hyperlipidemia. However, the mechanism of the hypocholesterolemic effect
of  SN still remains unclear. Therefore, the present study was aimed to evaluate the effect of
SN  extract particularly on cholesterol absorption and synthesis mechanisms.
Methods: For cholesterol absorption, the uptake of cholesterol was measured by using tritium
radiolabeling of cholesterol in Caco-2 cells. Bile acid binding, micelles size, and cholesterol
solubility were analyzed in in vitro assays, while cholesterol synthesis was evaluated by using
a  3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase assay kit.
Results: SN extract was found to decrease cholesterol uptake in Caco-2 cells and decreased
the solubility of cholesterol in micelles. The SN extract bound to taurocholate, tau-
rodeoxycholate, and glycodeoxycholate bile acids, and increased micelles size. SN has also
demonstrated an inhibitory effect on HMG-CoA reductase (HMGR) enzymatic activity. For
further experimentation, the treatment combination of SN and ezetimibe (0.04 mg/mL)
showed a greater signiﬁcant reduction in cholesterol uptake than the extract alone.
Conclusion: These observations suggested that inhibitory cholesterol absorption effects of
SN  could be mediated through the modulation of size and solubility of cholesterol micelles,
resulting in interference of cholesterol uptake. In addition, SN inhibited the rate limiting stepof  cholesterol synthesis. This study provides supporting evidence for the potential usage of
SN  as a cholesterol lowering agent.
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1.  Introduction
Cholesterol homeostasis is maintained by intestinal choles-
terol absorption, cholesterol synthesis, and excretion.1 Since
an excessively high level of plasma cholesterol is one of
the major risk factors for atherosclerosis and cardiovascu-
lar diseases,2 the reduction of cholesterol levels is desired
for hypercholesterolemia. Besides lifestyle modiﬁcation, med-
ications could be another recommended alternative for
management of hypercholesterolemia. Drugs such as statins
and ezetimibe are the common options. A statin, which is
a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reduc-
tase inhibitor, may exert its effect by suppressing cholesterol
biosynthesis pathway.3 Ezetimibe, a cholesterol absorption
inhibitor, plays a role in inhibiting cholesterol uptake into the
enterocyte by blocking the Niemann-Pick C1 like 1 (NPC1L1)
cholesterol transporter.3,4 However, several adverse events
associated with ezetimibe or statins used, e.g., hepatotoxicity,
severe cholestatic hepatitis,5 rhabdomyolysis, and myopathy,6
were reported. Therefore, functional foods and nutraceuticals
are becoming popular as alternative therapies for lowering
plasma cholesterol levels, especially in individuals whose
blood cholesterol levels are marginally high, but who are not
recommended to undergo drug treatments.7
Spirogyra neglecta (SN) is an edible freshwater macroalga
and a common ingredient used in Northern Thai cuisine.
SN contains many  nutritional constituents including fat,
proteins, carbohydrate, ﬁbers, multivitamins, minerals, and
antioxidants.8 In addition, it has been reported to exhibit
antigastric ulcer, antiinﬂammatory,9 antihyperglycemic, and
antihyperlipidemic properties.10 Recently, SN was able to
reduce plasma triglyceride in in type 2 diabetic rats.10 How-
ever, evidence to support the hypocholesterolemic effect of
SN and its mechanism still remains unclear. Normally, the
possible target is intestinal cholesterol absorption, which
has a major role in inﬂuencing plasma cholesterol level.11
Cholesterol absorption involves multistep processes includ-
ing digestion of dietary lipids and micellar solubilization of
cholesterol, and protein transporters.12 Therefore, we deter-
mined the impact of SN extract on cholesterol uptake by using
Caco-2 cells, in vitro bile acid binding, micelles size, and choles-
terol solubility. Meanwhile, the cholesterol synthesis study
was evaluated by using in vitro HMG-CoA reductase activity.
2.  Methods
2.1.  Chemicals
Dulbecco’s modiﬁed Eagle’s medium/F12, cholesterol, phos-
phatidylcholine, taurocholic acid (TC) sodium salt hydrate,
glycodeoxycholic acid (GC), taurodeoxycholic acid (TD),
cholestyramine, and the HMG-CoA reductase assay kit were
purchased from Sigma Chemical Co. (St. Louis, MO, USA).
Fetal bovine serum was purchased from Gibco (Carlsbad, CA,
USA). [1,2(n)-3H]Cholesterol was purchased from Perkin-
Elmer (Wellesley, MA,  USA). All other chemical reagents used
in this study were of analytical grade.Integr Med Res ( 2 0 1 6 ) 301–308
2.2.  Preparation  of  SN  extracts
Fresh whole SN was collected from Na Kuha village, Saun Kuen
subdistrict, Muang District, Phrae Province, Thailand. The SN
was rinsed and dried in an oven at 50 ◦C. Dried SN was ground
into a ﬁne powder and blended with water. In brief, dried SN
(100 g) was added into 2 L of distilled water and boiled at 100 ◦C
for 1 hour. The aqueous solution was then ﬁltered through
ﬁlter paper. The ﬁltrate was subsequently concentrated by
evaporation and lyophilized to dried extract powder by freeze
drying. The SN extract was stored at 4 ◦C prior to subsequent
experiments.
2.3.  Phytochemical  screening  of  SN  extract
The chemical constituents of aqueous extracts of SN were fur-
ther quantitated by the high-performance with diode array
detection and mass spectrometry detector (HPLC-DAD/MSD)
method on an Agilent Technologies 1100 series (Wald-
bronn, Germany), equipped with a Zorbax SB C18 column
(4.6 mm × 150 mm × 5 m)  (CA,USA) and diode array detector
recording at 270 nm,  330 nm,  350 nm,  and 370 nm.  The ﬂow
rate was 1 mL/min. The mobile phases were a binary sol-
vent system consisting of acetonitrile (Solvent A) and 10 mM
ammonium formate (pH 4 with formic acid; Solvent B), with
a gradient starting at 0:100 (A:B) for 5 minutes, 20:80 for
15 minutes, and the composition was changed to 40:60 over
40 minutes. Nitrogen was used as the nebulizing gas with a
ﬂow rate of 13 L/min at 320 ◦C. The capillary voltages were set
at 4 kV (positive) and 3 kV (negative). A scan time of 0.2 seconds
with a range of 100–700 m/z  was used. SN extract was analyzed
against phenolic standards. Semiquantitative data was ana-
lyzed by the peak area under the curve relative to the content
of each component in the extract.
2.4.  Cholesterol  micelles  preparation
The micelle solution was prepared and modiﬁed from
Yamanashi et al.13 Sodium taurocholate was dissolved in
methanol, and cholesterol and phosphatidylcholine were pre-
pared in chloroform. These mixer solutions were dried under
nitrogen gas. The hydrated lipid ﬁlm was dispersed under son-
ication in phosphate buffered saline (PBS) for 1 hour prior to
the experiment.
2.5.  Micellar  cholesterol  solubility  assay
The solubility of cholesterol in micelles was adapted from
Kirana et al.14 Brieﬂy, micelle solutions contained 10 mM
cholesterol, 1 mM sodium taurocholate, and 0.6 mM phos-
phatidylcholine. SN extract (0.1 mg/mL, 1 mg/mL, 10 mg/mL)
was added to the micelle solution and incubated at
37 ◦C for 3 hours. Mixed solutions were ﬁltered through
a 0.22-m membrane. The ﬁltrate was taken as micellardetermined by a cholesterol assay kit, which can be deﬁned
as micellar cholesterol solubility. The cholesterol micel-
lar solubility inhibition was calculated by using Eq. (1) as
follows:
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 Cholesterol solubility inhibition
= 100 −
(
Cholesterol contents (Treated)
Cholesterol contents (Control)
× 100
)
(1)
.6.  Cholesterol  micelles  size  determination
icelles solutions were prepared as mentioned above, and
etermination of micelles size in mixed solutions was mod-
ﬁed from Kirana, et al.14 SN extracts (150 L) at various
oncentrations (0.01 mg/mL, 0.1 mg/mL, 1 mg/mL, 10 mg/mL)
ere added to the micelle solution (1,350 L) and incubated at
7 ◦C for 3 hours. Micelles sizes were measured using a particle
ize analyzer which measures particle size from below 1 nm
o several microns using dynamic light scattering. The result
as represented as nanometer (nm).
.7.  Bile  acid  binding  determination
he bile acid binding assay was slightly modiﬁed the pro-
edure according to Yoshie-Stark and Wäsche,15 and as
reviously reported.16 TC, GC, and TD were used as bile
cids, while cholestyramine was used as a positive control
n this experiment. In brief, 200 L of SN extract (1 mg/mL) or
holestyramine (1 mg/mL) was incubated with 200 L of bile
cid (2 mM)  in 100 mM PBS, pH 7.0, at 37 ◦C for 2 hours. The
ixed solutions were centrifuged at 10,000 rpm for 10 minutes
nd passed through a 0.22 m membrane to separate the
ound from the free bile acids. The concentration of bile acid
as evaluated the following total bile acids methods.17 The
ltrated bile acid solutions (20 L) were mixed with 170 L
f reaction mixtures [0.133 mol/L tris buffer (pH 9.5), 1 mol/L
ydrazine hydrate, and 7.7 mmol/L nicotinamide adenine
inucleotide (NAD)] and 10 L of 1 unit/mL 3-hydroxysteroid
ehydrogenase. The mixed solutions were incubated at 30 ◦C
or 90 minutes. The rate of formation of thio-nicotinamide
denine dinucleotide (NADH) was determined by measuring
peciﬁc change of absorbance at 405 nm in a microplate reader.
.8.  Cell  culture  preparation
aco-2 cells were obtained from the American Type Culture
ollection. Cells were maintained at 37 ◦C in Dulbecco’s mod-
ﬁed Eagle’s medium/F12 containing 10% fetal bovine serum
nd 100 units/mL of penicillin, and 100 g/mL of streptomycin
n an incubator with 5% CO2 and saturated humidity.
.9.  Cell  viability  assay
he viability of cells was determined by the 3-(4,5-
imethylthiazol-2-yl)-2,3-diphenyl tetrazolium bromide
MTT) assay. Cells were cultured in 96-well plates at 10,000
ells/well and allowed to grow overnight. Cells were treated
ith the SN extract for 24 hours. Two hours before the end of
he treatment, 10 L of MTT  (5 mg/mL) were added. The plate
as washed with PBS before the purple formazan crystals
ere solubilized with 200 L of Dimethyl sulfoxide : Ethanol
DMSO:ETOH) (1:1; v/v) and measured at 595 nm.  Cell viability
as expressed as a percentage relative to the untreated.303
The % cell viability was calculated by using Eq. (2) as fol-
lows:
% Cell viability = OD595(Treated cells)
OD595(Untreated cells)
× 100 (2)
where OD is an optical density.
2.10.  Cholesterol  uptake  assay
Cholesterol micelles solutions were prepared as mentioned
above. The ﬁnal concentrations of micelle solutions were 1 M
cholesterol, 2 mM sodium taurocholate, 50 M phosphatidyl-
choline, and 1 Ci/mL [1,2(n)-3H]cholesterol. Caco-2 cells
were plated on a 24-well plate at 50,000 cells/well and
cultured for 14–21 days to allow differentiation. Fresh
medium was replaced every 2–3 days. The differentiated
Caco-2 cells were cultured in serum-free medium overnight
before treatment with single [SN extract (0.125 mg/mL,
0.25 mg/mL, 5 mg/mL, 1 mg/mL) or ezetimibe (0.004 mg/mL,
0.04 mg/mL, 0.08 mg/mL)] or combined dose [extract and eze-
timibe (0.04 mg/mL)] and [1,2(n)-3H]-cholesterol micelles for
4 hours. After washing the plate with ice-cold PBS twice,
cells were disrupted with 0.2 N NaOH/0.1% Triton-X 100. The
radioactivities of lysates were measured with a Packard -
counter and protein content by a BCA protein assay kit (Pierce,
Rockford, IL, USA).
Cholesterol uptake (% of control) was calculated by using
Eq. (3): as follows.
% Cholesterol uptake
= Radioactivities of cells/Protein contents (Treated cells)
Radioactivities of cells/Protein contents (Untreated cells)
× 100 (3)
2.11.  HMG-CoA  reductase  inhibitory  activity
The HMG-CoA reductase inhibitory activity was determined
using an HMG-CoA reductase assay kit from Sigma-Aldrich
(St. Louis, MO, USA). Ninety microliters of 1X buffer and 1 L
of SN extract (0.1 mg/mL), 2 L of nicotinamide adenine dinu-
cleotide phosphate (NADPH), and HMG-CoA concentrations
(400 M, 800 M, 1,600 M, and 3,200 M) were added in 96-well
plates. HMG-CoA reductase (1 L) will then be added to start
the reaction. The oxidation of NADPH to NADP+ was measured
by using a microplate reader at 340 nm with a kinetic program.
The enzyme activity was then expressed as a percentage of
inhibition. Pravastatin was used as a positive control in this
study.
2.12.  Statistical  analysis
The results were represented as mean ± standard error of the
mean (SEM). Each experiments were carried out as duplicate
and was repeated three times. The statistical signiﬁcance of
differences was evaluated by analysis of variance and Student
t test using statistical software in Microsoft Excel (Microsoft
304  Integr Med Res ( 2 0 1 6 ) 301–308
Table 1 – Phenolic constituents of aqueous Spirogyra
neglecta (SN) extracts
Phenolic compounds Aqueous SN
extract (mg/kg)
Gallic acid 565.29
Eriodictyol 347.68
Apigenin ND
Isoquercetin 5,500.44
Kaempferol 621.40
Quercetin 386.73
Hydroquinin 1,118.32
Rutin 700.40
Catechin 3,531.08
Tannic acid 548.91
Fig. 1 – Effect of Spirogyra neglecta (SN) on the solubility of
cholesterol micelles. SN extract (0.1 mg/mL, 1 mg/mL,
10 mg/mL) were  incubated with micelle solution at 37 ◦C for
3 hours. The solutions were  ﬁltered and then the
cholesterol content determined, which can be deﬁned as
micelar cholesterol solubility. Values are represented as
mean ± SEM (n = 3).
Signiﬁcant differences between untreated (control) and
treated (SN) percentages as follows:
* p < 0.005.
† p < 0.001.
To select the concentration of SN extracts for further exper-
iments, the extracts were tested for their cytotoxicity. SN at
Fig. 2 – Effect of Spirogyra neglecta (SN) on micelles sizes. SN
extracts (0.01 mg/mL, 0.1 mg/mL, 1 mg/mL, 10 mg/mL) were
incubated with micelle solution at 37 ◦C for 3 hours. The
solutions were measured for micelles size. Values are
represented as mean ± SEM (n = 3).
Signiﬁcant differences between untreated (control) and
treated (SN) percentages are as follows:ND, Not Detected.
Corporation, Redmond, WA, USA). Differences were consid-
ered signiﬁcant at p values < 0.05.
3.  Results
3.1.  Phenolic  constituents  of  aqueous  SN  extracts
The extraction yield with aqueous extract of SN was
30.5 ± 2.2%. The phytochemical screening of phenolic con-
stituents of aqueous SN extract showed the presence of
eriodictyol, isoquercetin, kaempferol, quercetin, hydroquinin,
rutin, catechin, and tannic acid (Table 1). Isoquercetin and
catechin displayed the main phenolic compounds in the SN
extract with 5,500.44 mg/kg and 3,531.08 mg/kg, respectively.
3.2.  Effect  of  SN  extract  on  micellar  cholesterol
solubility
The inhibition of micellar solubility of cholesterol was signiﬁ-
cantly increased in a dose-dependent manner in the presence
of SN extracts (0.1 mg/mL, 1 mg/mL, 10 mg/mL) as shown in
Fig. 1. SN extracts inhibited cholesterol solubility in the range
of 25–83%.
3.3.  Effect  of  SN  extract  on  cholesterol  micelles  size
SN extracts signiﬁcantly increased the particle size of choles-
terol micelles in a dose-response manner as nanometer
ranges (Fig. 2). SN extracts at 0.01 mg/mL, 0.1 mg/mL, 1 mg/mL,
and 10 mg/mL  increased the size when compared with control
by 1.7 times, 2.3 times, 3.5 times, and 11.8 times, respectively.
3.4.  Effect  of  SN  extract  on  bile  acid  binding
The SN extract and bile acids was evaluation total bile acid
using the 5th generation Randox total bile acids assay. The
rate of formation of Thio-NADH was determined by measuring
absorbance at 405 nm in a microplate reader. The percentage
of bile acid binding by SN extract (1 mg/mL) is shown in Table 2.
TC, GC, and TD were used as bile acids. SN extract bound to
TD and GC higher than cholestyramine. The extract bound
to TD, GC, and TC by 49.58%, 48.82%, and 24.01%, respectively.SEM, standard error of the mean.
Cholestyramine (1 mg/mL), a positive control, bound to TD, GC,
and TC by 36.47%, 26.87%, and 83.63%, respectively.
3.5.  SN  extract  on  cell  viability* p < 0.001.
†  p < 0.05.
SEM, standard error of the mean.
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Table 2 – In vitro binding of Spirogyra neglecta with bile acids
Samples Bile acid binding (% of control)
Taurocholate Taurodeoxycholate Glycodeoxycholate
Spirogyra neglecta 24.01 ± 2.76 49.58 ± 0.29* 48.82 ± 2.88*
Cholestyramine 83.63 ± 0.13* 36.47 ± 2.57* 26.87 ± 2.52*
Values represented as mean ± SEM (n = 3). Standard bile acid 2 mM. Sample concentrations 1 mg/mL.
∗ p < 0.01: signiﬁcant differences between untreated (control) and treated (
SEM, standard error of the mean.
Fig. 3 – Effect of Spirogyra neglecta (SN) extract on Caco-2
cells viability. Cells were  treated with the SN extract
(0.125 mg/mL, 0.25 mg/mL, 5 mg/mL, 1 mg/mL) for 24 hours.
Two hours before the end of the treatment,
3-(4,5-dimethylthiazol-2-yl)-2,3-diphenyl tetrazolium
bromide (MTT) was added. Cell viability was expressed as a
percentage relative to the untreated. Values are represented
as mean ± SEM (n = 3).
SEM, standard error of the mean.
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terol absorption mechanism in observed activity, the effect of.125–1 mg/mL  was observed to cause no effect on viability
f Caco-2 cells (Fig. 3). Therefore, the concentrations of SN at
.125–1 mg/mL  were selected for uptake experiments.
.6.  SN  extract  on  cholesterol  uptake  in  differentiated
aco-2  cells
N extract treatment showed a signiﬁcant dose-dependent
ecrease in cholesterol uptake in Caco-2 cells, as illustrated in
ig. 4. The extract at 0.5 mg/mL  and 1 mg/mL  decreased choles-
erol uptake by about 19% and 32%, respectively. Ezetimibe
nhibited the uptake of cholesterol approximately 15–54% in a
ose range from 0.004 mg/mL  to 0.08 mg/mL. Since SN extract
nd ezetimibe inhibited cholesterol uptake in Caco-2 cells,
here is a possibility that a combination of these two com-
ounds might further enhance the uptake inhibition activity.
he results showed that the combination of low concentra-
ion of SN extract (0.125 mg/mL) and ezetimibe (0.04 mg/mL)
aused a signiﬁcant enhancement in cholesterol uptake inhi-
ition, whereas the combination of a higher dosage of SN
xtract (0.25 mg/mL  and 0.5 mg/mL) and ezetimibe tends to
ecrease the uptake when compared with SN extract treat-
ent alone (Fig. 4).SN) percentages.
3.7.  SN  extract  on  HMG-CoA  reductase  activity
The HMG-CoA reductase inhibitory activities of SN extract are
shown in Fig. 5. Pravastatin (0.25 M)  was used as a standard
treatment agent for HMG-CoA reductase inhibitor activity.
From our experiments, SN extract (0.1 mg/mL) inhibited HMGR
activity and was believed to cause a direct binding to the
catalytic domain of HMGR along an increase of HMG-CoA con-
centrations (400 M, 800 M, 1,600 M, and 3,200 M)  by 38%,
88%, 75%, and 77% inhibition, respectively, as shown in Fig. 5.
However, there is a sign of saturation in HMGR activity as
demonstrated in results as a response to increasing HMG-CoA
concentration.
4.  Discussion
Literature showed SN was well studied for its antigastric
ulcer, antiinﬂammatory,9 antihyperglycemic, and antihyper-
lipidemic properties.10 Although a recent publication reported
that SN was found to exert its regulatory effect in animal
cholesterol levels, the exact mechanism of action, particu-
larly on the cholesterol absorption inhibition, is still unclear.
Cholesterol homeostasis involves a balance in intestinal
absorption, endogenous synthesis, bile acid activities, and
fecal excretion.18 Intestinal cholesterol absorption involves
several processes which include lipid digestion, micellar solu-
bilization, cholesterol release from micelles into enterocytes,
and secretion into lymph.12 The reduction of cholesterol
absorption by reducing micellar cholesterol solubility is
suggested for the treatment of hypercholesterolemia.14 Raed-
erstorff and coworkers19 suggested that the uptake of
cholesterol could interfere with the afﬁnity of micelles into
membranes and/or the afﬁnity of cholesterol in micelles.
Additionally, the binding of bile acids might act as a possi-
ble mechanism in regulating cholesterol levels. In detail, the
bile acid sequestrants bind to bile acids in the intestine result-
ing in the formation of an insoluble complex which can be
excreted in the feces. The activation of this process is known
to play an important role in regulating the cholesterol levels
in hypercholesterolemia condition.18,20 In order to assess the
inhibitory effect of SN extract on cholesterol absorption, Caco-
2 cells were used as model of experimentation speciﬁcally for
the cholesterol absorption study. Our results indicate that SN
extract decreased cholesterol uptake in Caco-2 cells. In our
attempt to address the possible involvement of the choles-SN extract on cholesterol micelles size and solubility and its
binding property to bile acids was studied. SN also demon-
strated a dose-dependent decrease in solubility of cholesterol
306  Integr Med Res ( 2 0 1 6 ) 301–308
Fig. 4 – Single and combined effects of Spirogyra neglecta (SN) extract and ezetimibe on cholesterol uptake in Caco-2 cells.
The differentiated Caco-2 cells were  treated with single [SN extract (0.125 mg/mL, 0.25 mg/mL, 5 mg/mL, 1 mg/mL) or
ezetimibe (0.004 mg/mL, 0.04 mg/mL, 0.08 mg/mL)] or combined dose [extract and ezetimibe (0.04 mg/mL)] and 1 Ci/mL
[1a,2a(n)-3H]-cholesterol micelle solution for 4 hours. Cells were disrupted and radioactivities and protein content measured.
Signiﬁcant differences are as follows:
* p < 0.05 [Compared between single dose of SN (0.125 mg/mL, 0.250 mg/mL, 0.5 mg/mL) and combination of SN and Eze
0.04 mg/mL].
† p < 0.05 {Compared between untreated [control] and treated [SN or ezetimibe (Eze)]}.
Fig. 5 – Effect of Spirogyra neglecta (SN) extract on 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitory
activity in vitro. The HMG-CoA reductase activity was determined using an HMG-CoA reductase assay kit. SN extracts
(0.1 mg/mL), NADPH, HMG-CoA concentrations (400 M,  800 M,  1600 M,  and 3200 M),  and HMG-CoA reductase were  used
in the reaction. Pravastatin was used as a positive control. The oxidation of NADPH was measured at 340 nm with a kinetic
program. Enzyme activity is expressed as a percentage of inhibition (mean ± SEM, n = 3).
Signiﬁcant differences between control and SN extract or pravastatin percentages are as follows:
* p < 0.001.
† p < 0.005.
, staNADPH, nicotinamide adenine dinucleotide phosphate; SEM
in micelles and a signiﬁcant increase in size of micelles. In
addition, SN revealed bile acids binding property (TC, GC, and
TD). In fact, Fernandez21 suggested that soluble-ﬁber polysac-
charides may play an important role in modifying the volume,
bulk, and viscosity of the intestinal lumen. These effects
were believed to interfere with the enterohepatic circulationndard error of the mean.
and lipoprotein metabolism which may cause a resulting
effect on lower cholesterol levels.21 Oat bran with native beta-
glucans, polysaccharides, increased fecal bile acid excretion,
as the -glucans in oat bran entrap or encapsulate whole
micelles in the small intestine.22 Besides, tea polyphenols
(epigallocatechin gallate) are known to interact with TCs in
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icellar solutions, eventually inhibiting the solubilization of
holesterol.23 Meanwhile, the polyphenols in grape seed (gal-
ic acid, catechin, and epicatechin) have high binding tendency
o bile acids, which will cause a reduction in the solubilization
f cholesterol in micelles.24 A similar activity was also found
n black tea polyphenols as they decrease the in vitro micel-
ar solubility of cholesterol and have been shown to interrupt
ntestinal cholesterol absorption in rats.25
In the present study, we found that SN contains polyphe-
olic compounds such as isoquercetin and catechin. Besides
olyphenolic compounds, SN was also known to possess
olysaccharides.26 Taken altogether, we postulated that the
ctivities exhibited by SN extract could be possibly linked to
he presence of polyphenols and polysaccharides. By contrast,
ntestinal cholesterol absorption can be speciﬁcally inhibited
y cholesterol absorption inhibitors (ezetimibe). However, the
reatment with ezetimibe showed no effect in NPC1L1 knock-
ut mice, suggesting that NPC1L1plays a role in the uptake
f cholesterol.4 Our results show for the ﬁrst time that SN
xtract inhibited cholesterol uptake, and the observed activ-
ty possibly acted through an inhibitory effect on cholesterol
ransporters. Therefore, the experiment evaluated the com-
inatory effect of SN extract and ezetimibe. The results
howed that the combination of SN extract and ezetim-
be (0.04 mg/mL) achieved a signiﬁcantly greater reduction
n cholesterol uptake than SN extract alone. However, the
ombinatory effect was still lower as compared to ezetimibe
reatment alone. In the combination, additive effect refers to
he sum of their effects, the synergistic effect refers to the
ffect which is greater than the sum of their effect, whereas
n antagonistic effect is the opposite of synergistic effect. Our
esults suggest that SN and ezetimibe decreased cholesterol
ptake and there was no synergetic effect with a combina-
ion of SN extracts and ezetimibe. Normally, ezetimibe does
ot completely inhibit cholesterol absorption, thus our results
mplied that SN may share the same mechanistic action sites
ith ezetimibe by inhibiting cholesterol transporter (NPC1L1)
nd/or effects on the internalization of transporter (NPC1L1)
etween intracellular compartments and membrane.
In cholesterol synthesis, HMG-CoA reductase is the rate
imiting step in cholesterol biosynthesis. Statins or HMG-CoA
eductase inhibitors are commonly used for management of
ypercholesterolemia. The presence of an HMG-like moiety on
hese drugs allows them to competitively bind to the catalytic
omain of the target enzyme, which results in an observed
nhibitory effect as shown in HMG-CoA reductase.27 In order
o assess the effect of SN extract on cholesterol synthesis
nhibition we  examined the effect of SNF on the activity of
MG-CoA reductase. SN extract and pravastatin showed a sig-
iﬁcant reduction in HMGR activity. The inhibition effect was
bserved to be increased in response to increasing HMG-CoA
oncentration and progressively reached its maximum activ-
ty or saturation. It can be noted that SN extract may have
aused a direct binding to the catalytic domain of HMGR. Islam
nd colleges28 reported that dietary polyphenols can reduce
holesterol biosynthesis by binding to HMGR and blocking the
28inding of nicotinamide adenine dinucleotide phosphate.
urcumin binds to the HMG-CoA site on the enzyme simi-
ar to the statins.28 Epigallocatechin gallate potently inhibits
MGR activity by competitively binding to the cofactor site307
of the reductase.28 Peng and coworkers29 suggested that
polyphenols-rich mulberry water extracts have hypolipidemic
properties via inhibiting lipid synthesis (decreased the expres-
sion of HMGR) and promoting lipid degradation.29 It can be
inferred that SN extract containing polyphenols may con-
tribute to inhibiting HMGR activity.
The current study demonstrated that SN extract could
inhibit cholesterol absorption and synthesis activities by mod-
ifying the size and solubility of cholesterol micelles with
involvement of the binding effect of bile acids. It was observed
to cause an effect by interrupting the cholesterol uptake, at the
same time inhibiting HMG-CoA reductase activity. The pres-
ence of bioactive ingredients in SN could be responsible for
the observed cholesterol lowering effect. Taken altogether, this
study provides the evidence for potential SN usage and possi-
ble development into a natural supplement for a cholesterol
lowering product. However, more  preclinical and perhaps clin-
ical studies might be needed for the safe use of this product.
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